ResearcherInnsbruck Medical UniversityNo recent work listed

Cornelia Speth

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5637-5993; OpenAlex author ID A5050981832. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment. Co-author DOI 10.3390/curroncol29120773 ↗
Micro- and Mycobiota Dysbiosis in Pancreatic Ductal Adenocarcinoma Development. First author DOI 10.3390/cancers13143431 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ruben Bellotti · 2 shared papers, 2021–2022 · strength 0.30
- Paper Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment. DOI 10.3390/curroncol29120773 ↗
- Paper Micro- and Mycobiota Dysbiosis in Pancreatic Ductal Adenocarcinoma Development. DOI 10.3390/cancers13143431 ↗
Manuel Maglione · 2 shared papers, 2021–2022 · strength 0.30
- Paper Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment. DOI 10.3390/curroncol29120773 ↗
- Paper Micro- and Mycobiota Dysbiosis in Pancreatic Ductal Adenocarcinoma Development. DOI 10.3390/cancers13143431 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.